395 results on '"Mikkola, Tomi S."'
Search Results
52. Misoprostol induces cervical nitric oxide release in pregnant, but not in nonpregnant, women
53. Estradiol Fatty Acid Esters in Adipose Tissue and Serum of Pregnant and Pre- and Postmenopausal Women
54. Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy
55. Increased Release of Cervical Nitric Oxide in Spontaneous Abortion before Clinical Symptoms: A Possible Mechanism for Preabortal Cervical Ripening
56. Postmenopausal hormone therapy before and after the womenʼs health initiative study: what consequences?
57. Comparison of Tibolone and Conjugated Equine Estrogens Effects on Carotid Artery Atherosclerosis of Postmenopausal Monkeys
58. Pelvic Organ Prolapse Repair Using the Uphold Vaginal Support System: 5-Year Follow-Up
59. Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study
60. Comparison of two retropubic tension-free vaginal tape procedures in women with stress urinary incontinence: a randomized controlled multicenter trial
61. Patient utilization survey of mirabegron prescribed for overactive bladder
62. Increased body fat mass and androgen metabolism – A twin study in healthy young women
63. Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy
64. Estrogen biosynthesis in breast adipose tissue during menstrual cycle in women with and without breast cancer
65. Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy
66. Metabolism of sex steroids is influenced by acquired adiposity—A study of young adult male monozygotic twin pairs
67. In Reply
68. Quality of life after Uphold™ Vaginal Support System surgery for apical pelvic organ prolapse—A prospective multicenter study
69. Lower Death Risk for Vascular Dementia than for Alzheimer’s Disease with Postmenopausal Hormone Therapy Users
70. Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use
71. C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome
72. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study
73. Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies
74. Cardiac repolarization in recently postmenopausal women with or without hot flushes
75. Steroid sulfatase activity in subcutaneous and visceral adipose tissue: a comparison between pre- and postmenopausal women
76. Quantitative determination of estrone by liquid chromatography–tandem mass spectrometry in subcutaneous adipose tissue from the breast in postmenopausal women
77. Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy
78. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality
79. Hysterectomies In Finland in 1990–2012—Comparison of Outcomes Between Trainees and Specialists
80. The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study
81. Steroid sulfatase activity in adipose tissue is higher in postmenopausal than premenopausal women
82. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: A practical guide
83. Postmenopausal hot flushes and bone mineral density: a longitudinal study
84. Premenstrual symptoms in fertile age are associated with impaired quality of life, but not hot flashes, in recently postmenopausal women
85. Health-related quality of life in women with or without hot flashes
86. NFOG Educational Course: harmonizing and improving the Nordic ObGyn training – how to get there?
87. Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women
88. Sex Differences in Age-Related Cardiovascular Mortality
89. Menopausal hot flashes and insulin resistance
90. Effect of aerobic training on menopausal symptoms—a randomized controlled trial
91. High-risk human papillomavirus-induced expression of endothelial and inducible nitric oxide synthase in human uterine cervix
92. Vasomotor hot flashes and heart rate variability
93. Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users.
94. Hormone therapy and vasomotor symptoms
95. The hot flush—A determinant for vascular effects of estrogen?
96. Quantitative determination of dehydroepiandrosterone fatty acyl esters in human female adipose tissue and serum using mass spectrometric methods
97. Menopausal hot flushes and vascular health
98. Cervical nitric oxide release and persistence of high-risk human papillomavirus in women
99. Postmenopausal Hormone Therapy Increases Retinal Blood Flow and Protects the Retinal Nerve Fiber Layer
100. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.